Skip to main content
. 2022 Aug 2:1–15. Online ahead of print. doi: 10.1007/s10238-022-00856-7

Fig. 7.

Fig. 7

Survival analysis for expression of CD300e in MDS patients. a Overall survival, progression-free survival and no AML evolution curves survival of MDS patients with different CD300e expression. b Overall survival, progression-free survival and no AML evolution survival curves of higher risk MDS patients with different CD300e expression